Spots Global Cancer Trial Database for myeloproliferative disease
Every month we try and update this database with for myeloproliferative disease cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Correlative Biomarker Study in Patients With Myeloproliferative Disorders | NCT00665067 | Myeloproliferat... Myelofibrosis Idiopathic Myel... Essential Throm... Polycythemia Ve... | 18 Years - | Icahn School of Medicine at Mount Sinai | ||
| Correlative Biomarker Study in Patients With Myeloproliferative Disorders | NCT00665067 | Myeloproliferat... Myelofibrosis Idiopathic Myel... Essential Throm... Polycythemia Ve... | 18 Years - | Icahn School of Medicine at Mount Sinai | ||
| Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation | NCT01800643 | Acute Leukemia Chronic Leukemi... Lymphoprolifera... Myeloproliferat... Immunodeficienc... | Analyze the pha... | - | Hospital Israelita Albert Einstein | |
| Research Tissue Bank | NCT00666549 | Myelofibrosis Idiopathic Myel... Essential Throm... Polycythemia Ve... | 18 Years - | Icahn School of Medicine at Mount Sinai | ||
| Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation | NCT01800643 | Acute Leukemia Chronic Leukemi... Lymphoprolifera... Myeloproliferat... Immunodeficienc... | Analyze the pha... | - | Hospital Israelita Albert Einstein | |
| T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE | NCT00578461 | Leukemia Cancer Lymphoma Lymphoma, Hodgk... Lymphoma, Non-H... | Ara C Mesna Cyclophosphamid... TBI-Total Body ... | - 64 Years | Baylor College of Medicine | |
| Safety and Efficacy of 72-hour and 120-hour Infusion of Rigosertib in Acute Myeloid Leukemia (AML) and Acute Lymphoid Leukemia (ALL) | NCT01167166 | Acute Myelocyti... Acute Lymphocyt... Myeloproliferat... Chronic Myeloid... | rigosertib | 18 Years - | Traws Pharma, Inc. | |
| Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis | NCT01749111 | Acute Myelogeno... Acute Lymphoid ... Myeloproliferat... Myelodysplastic... Chronic Myeloid... Chronic Myelomo... | ARM A Cyclophos... ARM B Calcineur... | 18 Years - 60 Years | Hospital Israelita Albert Einstein | |
| Evaluation of Inflammatory Markers in ph Negative Myeloproliferative Neoplasms: Impact on Outcome and Response to Therapy. Multicenter Retro-prospective Observational Study. The INFLA-ME (INFLAmmation in Myeloproliferative Disease) Study. | NCT05553873 | Myeloproliferat... Inflammatory Ma... | 18 Years - 99 Years | University of Milano Bicocca | ||
| Research Tissue Bank | NCT00666549 | Myelofibrosis Idiopathic Myel... Essential Throm... Polycythemia Ve... | 18 Years - | Icahn School of Medicine at Mount Sinai | ||
| T-Regulatory Cell Kinetics, Stem Cell Transplantation, REGKINE | NCT00578461 | Leukemia Cancer Lymphoma Lymphoma, Hodgk... Lymphoma, Non-H... | Ara C Mesna Cyclophosphamid... TBI-Total Body ... | - 64 Years | Baylor College of Medicine |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
